ArticleBasic and clinical andrology2025
L-Proline supplementation preserves sperm function and chromatin integrity in asthenozoospermic patients during cryopreservation.
Article in Basic and clinical andrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAsthenozoospermia is a major cause of male infertility, accounting for approximately 18% of infertility cases. L-Proline, a natural antioxidant and osmoprotectant, has gained attention for its potential applications in semen cryopreservation. This study aimed to evaluate the beneficial effects of L-proline on sperm quality in samples from asthenozoospermic patients during cryopreservation.
resultsThis in vitro experimental study utilized semen samples from 30 men (aged 27-40 years) diagnosed with asthenozoospermia. Each sample was divided into three aliquots for cryopreservation: (1) a control group using a standard unsupplemented freezing medium; (2) a group supplemented with 2 mM L-proline; and (3) a group supplemented with 4 mM L-proline. Following thawing, samples were assessed for sperm count, motility, viability, morphology, and chromatin quality. Additionally, levels of malondialdehyde (MDA), total antioxidant capacity (TAC), and nitric oxide (NO) were assessed. Supplementation with 2 mM L-proline resulted in significantly higher post-thaw progressive motility, viability, and chromatin integrity compared to the control group (p < 0.05). These functional improvements were associated with a more favorable antioxidant status, evidenced by significantly lower levels of MDA and NO and higher levels of TAC (p < 0.05). While the 4 mM L-proline group showed some protection, the effects were less pronounced than those observed with the 2 mM concentration.
conclusionsThe results suggest that adding 2 mM L-proline into the freezing medium effectively protects human sperm quality and chromatin integrity in asthenozoospermic samples by mitigating cryopreservation-induced nitro-oxidative stress. This strategy holds promise for improving assisted reproductive technology (ART) outcomes in men with asthenozoospermia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.